FAM110A could serve as a prognostic biomarker for patients with breast cancer: A comprehensive analysis by integrating bulk and single-cell sequencing

Asian J Surg. 2024 May 9:S1015-9584(24)00901-1. doi: 10.1016/j.asjsur.2024.05.014. Online ahead of print.

Authors

Qian Ni¹, Huijuan Zhang¹, Jiannan Liu², Ping Sun³

Affiliations

¹ Department of Oncology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, China.
² Department of Oncology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, China. Electronic address: liujiannansun2013@163.com.
³ Department of Oncology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, China. Electronic address: sunping20039@Hotmail.com.

PMID: 38729881
DOI: 10.1016/j.asjsur.2024.05.014

No abstract available

Keywords: BRCA; FAM110A; Prognosis; Tumor immune microenvironment.

Publication types

Letter